Nasdaq:US$15.32 (+0.31) | HKEX:HK$24.34 (+0.02) | AIM:£2.24 (-0.03)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 30 Nov 2010

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)